<i>IGF1</i> Haploinsufficiency: Phenotype and Response to Growth Hormone Treatment in 9 Patients

Author:

Punt Lauren D.,van der Kaay Daniëlle C.M.,van Setten Petra A.,de Groote Kirsten,Kruijsen Anne R.,Bocca Gianni,de Munnik Sonja A.,Renes Judith S.,de Bruin Christiaan,Losekoot Monique,van Duyvenvoorde Hermine A.,Wit Jan M.ORCID,Joustra Sjoerd D.

Abstract

<b><i>Introduction:</i></b> The clinical features of bi-allelic <i>IGF1</i> defects are well established, i.e., severe growth failure and microcephaly, delayed psychomotor development, and sensorineural deafness. However, information on clinical and endocrine consequences of heterozygous <i>IGF1</i> variants and treatment options is scarce. We aimed at extending the knowledge base of the clinical presentation and growth response to recombinant human growth hormone (rhGH) of patients carrying such variants. <b><i>Methods:</i></b> Retrospective case series of patients with pathogenic heterozygous <i>IGF1</i> variants. <b><i>Results:</i></b> Nine patients from six families were included, harbouring five whole or partial gene deletions and one frameshift variant resulting in a premature stop codon (three de novo, one unknown inheritance). In the other two families, variants segregated with short stature. Mean (SD) birth length was −1.9 (1.3) SDS (<i>n</i> = 7), height −3.8 (0.6) SDS, head circumference −2.5 (0.6) SDS, serum IGF-I −1.9 (0.7) SDS, serum IGFBP-3 1.1 (0.4) SDS (<i>n</i> = 7), and GH peak range 5–31 μg/L (<i>n</i> = 4). Five patients showed feeding problems in infancy. Average height increased after 1 and 2 years of rhGH treatment by 0.8 SDS (range 0.3–1.3 SDS) and 1.3 SDS (range 0.5–2.0 SDS), respectively. Adult height in 2 patients was −2.8 and −1.3 SDS, which was, respectively, 1.3 and 2.9 SDS taller than predicted before start of treatment. <b><i>Conclusion:</i></b> Haploinsufficiency of <i>IGF1</i> causes a variable phenotype of prenatal and postnatal growth failure, microcephaly, feeding difficulties, low/low-normal serum IGF-I values in contrast to serum IGFBP-3 in the upper-normal range. Treatment with rhGH increased growth in the first 2 years of treatment, and in 2 patients adult height after treatment was higher than predicted at treatment initiation.

Publisher

S. Karger AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3